Physician profile
Jose A Ramirez
NPI 1841239134
$3,140.05
in general payments reported to CMS, 2019-2025
17 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $537 · 2021: $749 · 2022: $1,003 · 2023: $64.27 · 2024: $106 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $822.36 | 2019-2025 | Venclose Maven Catheter |
| Surmodics, INC. | $440.29 | 2022-2024 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Lemaitre Vascular, INC. | $375.00 | 2020 | |
| Philips North America LLC | $346.34 | 2022 | |
| W. L. Gore & Associates, INC. | $221.47 | 2021 | |
| Medtronic Vascular, INC. | $200.66 | 2019 | |
| Medtronic, INC. | $153.75 | 2022-2025 | Hawkone, Abre |
| Organogenesis INC. | $142.04 | 2022-2023 | Puraply |
| Getinge USA Sales, LLC | $141.78 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $73.85 | 2019 | |
| Aroa Biosurgery Incorporated | $62.54 | 2025 | |
| Kerecis Limited | $56.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Cook Medical LLC | $36.75 | 2021 | |
| Becton, Dickinson and Company | $29.05 | 2024 | Venclose Maven Catheter |
| Abbott Laboratories | $19.17 | 2023 | Supera |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $18.14 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.